IS ARTIFICIAL INTELLIGENCE STILL WORTH THE HYPE?
The buzz around artificial intelligence (AI) is undeniable, but is it all worth it? It’s clear that the excitement that once surrounded AI investments is starting to fizzle out. The critical work ahead now involves separating the real opportunities from the flashy rebranding of business as usual.
PHARMA AND AI: A WINNING COMBINATION?
Pharmaceutical companies diving into the AI world need to answer three key questions. Are they integrating AI into their main area of expertise – treatment development? Will their approach stand out? And, are they dedicating the right resources to unleash the full potential of AI? Investors need to know the answers to these questions to pick the companies poised for success.
AI IN HEALTHCARE: THE FUTURE OF TREATMENT
There’s a lot of AI-based healthcare products out there, but one type is truly revolutionizing patient treatment: Software as a Medical Device (SaMD), particularly prescription digital therapeutics (PDTs). These next-generation programs use AI to personalize the treatment journey, creating new value within the healthcare industry. Investors should take notice of these game-changing opportunities.
PDTs: MORE THAN JUST AI
Prescription digital therapeutics stand out from the crowd by offering three key advantages. They form personalized, long-term partnerships with patients, generate rich, long-term datasets, and provide real-time, precision care. The value that these programs offer is significant, but companies must invest the necessary resources to bring them to life.
THE BOTTOM LINE: INVESTING IN THE FUTURE
The future of healthcare is being shaped by AI, especially in the field of patient treatment. The potential is there, but companies need to back up their vision with real investment. Those that can make it happen will be leading the charge into the AI-enabled patient journey of the future. So, what do you think? Do you believe AI will truly revolutionize patient care, or is it just a flashy trend? Leave a comment and let us know your thoughts!
IntelliPrompt curated this article: Read the full story at the original source by clicking here